The prevalence of glucose-6-phosphate dehydrogenase deficiency in the Cape Verdean population in the context of malaria elimination.

Cabo Verde aims to eliminate malaria by 2020. In the country, Plasmodium falciparum had been the main parasite responsible for indigenous cases and primaquine is the first line treatment of cases and for radical cure. However, the lack of knowledge of the national prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency may be one of the constraints to the malaria elimination process.

Spatiotemporal characterisation and risk factor analysis of malaria outbreak in Cabo Verde in 2017.

Background: Cabo Verde is a country that has been in the pre-elimination stage of malaria since the year 2000. The country is still reporting cases, particularly in the capital of Praia, where more than 50% of the national population live. This study aims to examine the spatial and temporal epidemiological profile of malaria across the country during the 2017 outbreak and to analyse the risk factors, which may have influenced the trend in malaria cases.

Achievement of malaria pre-elimination in Cape Verde according to the data collected from 2010 to 2016.

Background: Malaria, despite being preventable and treatable, continues to be a major public health problem worldwide. The archipelago nation of Cape Verde is in a malaria pre-elimination phase with the highest potential to achieve the target goal of elimination in 2020.

Methods: Nationwide malaria epidemiological data were obtained from the Cape Verde health information system that includes the individual malaria case notification system from all of the country's health structures.